2nd Annual Precision Liver Symposium
@precisionliver
Followers
58
Following
0
Media
26
Statuses
31
The Second Annual Thursday Liver Symposium: Dawn of a New Era in Precision Medicine: Genetics and Biomarkers in Liver Disease and Cirrhosis
Washington, DC
Joined October 2024
Join us at the Thursday Liver Symposium for an expert session with Dr. Naim Alkhouri, MD, FAASLD, DABOM — “Event Rate in MASH Cirrhosis Trials by VCTE: Assessment of the Phase 3 Trial Landscape.” Register: https://t.co/g8ORkSWwLP
0
0
0
Dr. Rohit Loomba leads Second Annual Thursday Liver Symposium on November 6th - Register Now!: https://t.co/g8ORkSWwLP
@DrLoomba
0
0
2
🔥 Debate Spotlight : Should patients with burnt-out NASH be included in cirrhosis trials? Don’t miss this thought-provoking session as two leading experts go head-to-head on one of the most important questions in liver research. 👉 Register now: https://t.co/g8ORkSWwLP
0
0
1
Register now for the Second Annual Thursday Liver Symposium on Thursday, November 6th! Don’t miss Dr. Rohit Loomba as he presents new data on cT1, MRE, and MRI-PDFF in treatment response. @DrLoomba 👉 Secure your spot now!: https://t.co/NajgvUc2Rs
0
0
1
Don’t miss this session at the Thursday Liver Sympo! 📢 Guadalupe Garcia-Tsao, MD, FRCP will break down the key NEJM papers on SLD and cirrhosis, highlighting the latest evidence and what it means for patient care. 👉 Seats are limited—register now at https://t.co/g8ORkSWwLP
1
1
2
Learn from the experts at the Second Annual Thursday Liver Symposium! Cutting-edge updates, practical strategies, and leading voices in liver care—all in one event. Register now: https://t.co/g8ORkSWwLP
0
11
19
Join us in Washington, DC! The Second Annual Thursday Liver Symposium takes place November 6th. Don’t miss this opportunity to connect, learn, and advance care in liver disease. 👉 https://t.co/g8ORkSWwLP
0
0
0
Dr. Rohit Loomba leads the Second Annual Thursday Liver Symposium on November 6th - Register Now!: https://t.co/g8ORkSWwLP
0
0
3
Kick starting @MetALDconf in San Diego how to diagnose metALD in clinic ? @AjmeraVeeral @AASLDtweets @AmerGastroAssn @QAnstee @AleksanderKrag
0
11
42
Great talk @juanpabloarab on the impact of alcohol use in the natural history of SLD at the @MetALDconf . Assessment of alcohol intake over time should be standardized in clinical practice. @VCU @VCU_Liver @DrLoomba @MarcoArreseMD @rabataller @ArunJSanyalVCU
1
4
33
Pros and cons of current NITs in MetALD. Inflammation, excess weight, alcohol use and low specificity are the main caveats of NITs. Fantastic talk from @MajaThiele at the @MetALDconf ! #LiverTwitter @DrLoomba @AleksanderKrag @EASLedu @EASLnews @MASLDResearch
1
7
28
How to innovate in MetALD clinical trials? @DrLoomba provided relevant considerations for security and endpoints. NITs biomarkers may play a role in early phase studies! @MASLDResearch @f_tavaglione @DrMaralMD @AjmeraVeeral @MonicaTincopa @UCSD_GI #LiverTwitter @MetALDconf
0
6
23
Ending the day with the Emerging Biomarkers and Endpoints panel discussion!
0
0
0
Excessive Alcohol Use and Alcohol Use Disorder in MetALD Trials session discussion with our esteemed panelists!
0
0
0
Thank you to the MetALD Conference faculty for an excellent day of lectures and insightful learning!
0
2
19
Natural History and Biomarkers of Liver Injury and Alcohol Use in MetALD Panel Discussion live at the MetALD Conference!
0
0
1
Session One Panel Discussion at the MetALD Conference!
0
1
4
Course Director Rohit Loomba, MD MHSc kicking off the MetALD Conference in San Diego! @Drloomba
0
1
7
We’re proud to sponsor this year’s @MetALDconf exploring the opportunities & challenges in #clinical drug development as we continue to advance innovative therapeutics for patients with #metabolic dysfunction-associated liver diseases: https://t.co/tgTOArKdcp
0
3
13
There's Still Time To Register for the San Diego: MetALD Conference!
0
1
2